Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (338) Arrow Down
Filter Results: (338) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (338)
    • News  (34)
    • Research  (273)
  • Faculty Publications  (228)

Show Results For

  • All HBS Web  (338)
    • News  (34)
    • Research  (273)
  • Faculty Publications  (228)
← Page 16 of 338 Results →
  • May 2025 (Revised June 2025)
  • Supplement

Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (D)

By: Linda A. Hill and Lydia Begag
This fourth installment in the Pfizer Global Clinical Supply (GCS) transformation case series highlights how over a decade of cultural and digital evolution positioned GCS to meet unprecedented global challenges. In 2011, Michael Ku became the Vice President of GCS and... View Details
Keywords: Innovation Leadership; Technological Innovation; Leadership Development; Leadership Style; Research and Development; Science-Based Business; Transformation; Health Pandemics; AI and Machine Learning; Analytics and Data Science; Digital Transformation; Leading Change; Product Launch; Supply Chain; Organizational Change and Adaptation; Alignment; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; Asia; Europe; Latin America
Citation
Purchase
Related
Hill, Linda A., and Lydia Begag. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (D)." Harvard Business School Supplement 425-079, May 2025. (Revised June 2025.)
  • January 2007 (Revised January 2007)
  • Background Note

Note on the U.S. Food and Drug Administration

By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

drive HNA's continued growth. Purchase this case: http://harvardbusinessonline.hbsp.harvard.edu/ b01/en/common/item_detail.jhtml?id=309029 Maggie Lena Walker and the Independent Order of St. Luke Harvard Business School Case 409-057 As View Details
Keywords: Martha Lagace
  • Research Summary

Overview

Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ... View Details
Keywords: Electricity; Prosumer; Smart Grid; Blockchain; Microgrid; Electric Vehicles; Batteries; Energy Storage; Ride-sharing; Smart Cities; Smart Buildings; Smart Meters; Demand Response; "GMOs,"; Corporate Accountability; Responsibilities To Society; Environmental And Social Sustainability; Leadership & Corporate Accountability; Competitive Strategy; Innovation Strategy; Disruptive Innovation; Research and Development; Leadership; Environmental Sustainability; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Asia; United States
  • 2001
  • Other Unpublished Work

Clusters of Innovation Initiative: San Diego

By: Michael E. Porter
The study contains a conceptual framework for assessing the competitiveness of regional economies, an analysis of the San Diego region overall, as well as detailed assessments of two representative clusters—biotechnology/pharmaceuticals and communications. The report... View Details
Keywords: Clusters; Economics; Industry Clusters; Economy; Growth and Development; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; San Diego
Citation
Read Now
Related
Porter, Michael E. "Clusters of Innovation Initiative: San Diego." Council on Competitiveness, Washington, DC, May 2001. (Report.)
  • 01 Dec 2001
  • News

Reaching Out

Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one month after finishing his... View Details
Keywords: Garry Emmons and Julia Hanna; Health, Social Assistance
  • June 2024
  • Supplement

Legacy Partners (A)

By: Richard S. Ruback and Royce Yudkoff
Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; California
Citation
Purchase
Related
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (A)." Harvard Business School Multimedia/Video Supplement 224-725, June 2024.
  • 11 Nov 2015
  • Working Paper Summaries

Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

Keywords: by Danielle Li; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • 01 Jun 2011
  • News

The Best-Laid Plans

failed companies. When Potentia Pharmaceuticals won the contest in 2001 with Alec Machiels (MBA 2001) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug... View Details
Keywords: Julia Hanna; contests; Health, Social Assistance; Architectural, Engineering, and Related Services; Professional Services; Management, Scientific, and Technical Consulting Services; Professional Services
  • 18 Aug 2011
  • Lessons from the Classroom

Business Plan Contest: 15 Years of Building Better Entrepreneurs

asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with failed companies. When... View Details
Keywords: by Julia Hanna; Education
  • 01 Dec 2010
  • News

How to Survive Past Start-up

Cenedella tried several other ideas for job-industry companies before he came up with the idea for TheLadders. Michel spent years searching for the right business idea — even helping to start a pharmaceutical industry computer firm —... View Details
Keywords: Bill Murphy Jr.; News, Library, Internet, and Other Services; Information; Health and Personal Care Stores; Retail Trade
  • 01 Dec 2008
  • News

A Force for Good

do. He and Dick Nesson considered trying to set up a “health-care high school” in Boston, but the educational bureaucracy proved insurmountable. Reflecting his continuing interest in health care, he joined the board of pharmaceutical... View Details
Keywords: Jeffrey L. Cruikshank; Construction of Buildings; Construction; Monetary Authorities-Central Bank; Finance; Hospitals; Health, Social Assistance; Publishing Industries (except Internet); Information; Wood Product Manufacturing; Manufacturing; Rail Transportation; Transportation
  • 01 Sep 2014
  • News

All For One

industries as diverse as automobiles and pharmaceuticals and began to interview and observe them to see how they created environments ripe for innovation. “We didn’t want to just espouse platitudes,” Hill says. “We wanted to tell full... View Details
Keywords: Michael Blanding; faculty; research; Market Research, Photo, Translation, Veterinary and Other Services; Professional Services
  • 24 Sep 2007
  • Research & Ideas

The FDA: What Will the Next 100 Years Bring?

food, medicine, or cosmetics you use. Consumers would end up restricting what they buy to a few trusted brands. In effect, the FDA has made competition possible in consumer products and even in pharmaceuticals (particularly through the... View Details
Keywords: by Sean Silverthorne; Biotechnology; Consumer Products; Food & Beverage; Health
  • March 2015
  • Teaching Note

CVS Health: Promoting Drug Adherence

By: Leslie John, John Quelch and Robert Huckman
Email mking@hbs.edu for a courtesy copy.

This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Purchase
Related
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Teaching Note 515-086, March 2015. (Email mking@hbs.edu for a courtesy copy.)
  • 26 Apr 2011
  • Op-Ed

HBS Faculty Comment on Environmental Issues for Earth Day

what we have learned about how best to accelerate innovation from industries like IT and pharmaceuticals - sectors in which the US leads the world and which saw enormous rates of technical progress over the last fifty years. The results... View Details
Keywords: by Staff; Energy; Utilities
  • December 2021
  • Case

Zoetis

By: David E. Bell, Damien McLoughlin and Natalie Kindred
Keywords: Strategy; Food; Change Management; Leadership; Diversity; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Bell, David E., Damien McLoughlin, and Natalie Kindred. "Zoetis." Harvard Business School Case 522-041, December 2021.
  • 01 Dec 2010
  • News

This Is What I Do

thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety biotech... View Details
Keywords: Garry Emmons; time travel; Health, Social Assistance; Accommodation; Hospitality; News, Library, Internet, and Other Services; Information; Apparel Manufacturing; Manufacturing
  • July 2014 (Revised February 2015)
  • Teaching Note

Johnson & Johnson: The Promotion of Wellness

By: John A. Quelch
The chief medical officer of Johnson & Johnson (J & J) is reflecting on forty years of sustained efforts by the company to improve employee wellness. The case reviews J & J's multiple wellness initiatives and efforts to measure their effectiveness. It also invites... View Details
Keywords: Empoylee Wellness Programs; Human Resource Management; Corporate Management Strategy; Employee Engagement; Human Resources; Management; Organizations; Performance; Personal Development and Career; Programs; Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; North and Central America; Europe; Asia
Citation
Purchase
Related
Quelch, John A. "Johnson & Johnson: The Promotion of Wellness." Harvard Business School Teaching Note 515-021, July 2014. (Revised February 2015.)
  • 10 Jan 2005
  • Research & Ideas

Motivation and the Cross-Sector Alliance

With cross-sector collaborations on the rise, a new book exploring partnerships between business and social organizations in the Americas comes at just the right time. Social Partnering in Latin America: Lessons Drawn from Collaborations... View Details
Keywords: by James Austin, Ezequiel Reficco & SEKN research team
  • ←
  • 16
  • 17
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.